are you comparing PYC therapeutics
1) retinosa pigmentosa study
2) optic atrophy study
3) AD polycystic kidney disease
4) phelan mcderaid disease
to ATH?
or are comparing a similar consolidation?
can you be specific rather than vague with what you are implying?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.5¢ | $787.6K | 48.96M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 9250665 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 6931087 | 13 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |